N-[(3R,4S)-3-hydroxy-3-methyl-9-[(3-methylimidazol-4-yl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl]methanesulfonamide
C16H28N4O4S — CID 155987500
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[(3R,4S)-3-hydroxy-3-methyl-9-[(3-methylimidazol-4-yl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl]methanesulfonamide
N-[(3R,4S)-3-hydroxy-3-methyl-9-[(3-methylimidazol-4-yl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl]methanesulfonamide (PubChem CID 155987500) has the molecular formula C16H28N4O4S and a molecular weight of 372.49 g/mol. Its IUPAC name is N-[(3R,4S)-3-hydroxy-3-methyl-9-[(3-methylimidazol-4-yl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[(3R,4S)-3-hydroxy-3-methyl-9-[(3-methylimidazol-4-yl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl]methanesulfonamide |
|---|---|
| PubChem CID | 155987500 |
| Molecular Formula | C16H28N4O4S |
| Molecular Weight | 372.49 g/mol |
| Exact Mass | 372.18 |
| IUPAC Name | N-[(3R,4S)-3-hydroxy-3-methyl-9-[(3-methylimidazol-4-yl)methyl]-1-oxa-9-azaspiro[5.5]undecan-4-yl]methanesulfonamide |
| SMILES | Cn1cncc1CN1CCC2(CC1)C[C@H](NS(C)(=O)=O)[C@@](C)(O)CO2 |
| InChI | InChI=1S/C16H28N4O4S/c1-15(21)11-24-16(8-14(15)18-25(3,22)23)4-6-20(7-5-16)10-13-9-17-12-19(13)2/h9,12,14,18,21H,4-8,10-11H2,1-3H3/t14-,15-/m0/s1 |
| InChIKey | KQMDTDGGYQFNTF-GJZGRUSLSA-N |
| XLogP | -0.16 |
| TPSA | 96.69 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 372.49 |
| LogP ≤ 5 | -0.16 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155987500 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.